Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study-Reference-Cited by-同舟云学术

Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study

Published:2016-10-14 Issue:12 Volume:5 Page:e1242546
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Yu,Zhao Xiang-Yu,Xu Lan-Ping,Zhang Xiao-Hui,Han Wei,Chen Huan,Wang Feng-Rong,Mo Xiao-Dong,Zhang Yuan-Yuan,Zhao Xiao-Su,Y. Kong,Liua Kai-Yan,Huang Xiao-Jun,Yu Xue-Zhong,Chang Ying-Jun

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1242546

Reference38 articles.

1. Who is the best donor for a related HLA haplotype-mismatched transplant?

2. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

3. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

4. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

5. Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies;Bone Marrow Transplantation;2021-07-08

2. Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation;Frontiers in Immunology;2020-02-14

3. Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2020-01

4. Natural killer cell-based immunotherapy with CTLA4Ig-primed donor lymphocytes following haploidentical transplantation;Immunotherapy;2019-10

5. Donor selection for haploidentical hematopoietic cell transplantation‐ practice guidance;ADVANCES IN CELL AND GENE THERAPY;2018-12-21